• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jason Mitchell: How Freestanding EDs Can Be Utilized in Shift to Value-Based Care

Video

Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses how freestanding emergency departments can be utilized in the move toward value-based care.

Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services, discusses how freestanding emergency departments can be utilized in the move toward value-based care.

Transcript

How can freestanding emergency departments be utilized in the move toward value-based care?

Our goal at Presbyterian is to really drop the cost of care, and one of the ways to do that is to allow people to get urgent care when they need urgent care and emergency care when they need that. We found that in our EDs [emergency departments], 16% of those individuals that were there did not need ED visits. So, we’re building freestanding urgent care and urgent care services and designing them so that they really drop the cost of care. Everyone that comes into that ED is considered urgent care, and only if they need ED resources do we bill an ED visit. It saves the patients money in co-pays, it saves the insurance companies money, it drops the cost of care. It really is a revolutionary way to do this.

We take all payers and contract with every payer, and we never balance bill a patient. So, we’ve created a higher value system for our patients and our members in a way that equitable and serves the entire community.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.